section name header

Table 117-2

Initial Evaluation of Cardiomyopathy

Clinical Evaluation

Thorough history and physical examination to identify cardiac and noncardiac disordersa

Detailed family history of heart failure, cardiomyopathy, skeletal myopathy, conduction disorders and tachyarrhythmias, sudden death

History of alcohol, illicit drugs, chemotherapy, or radiation therapya

Assessment of ability to perform routine and desired activitiesa

Assessment of volume status, orthostatic blood pressure, body mass indexa

Laboratory Evaluation
Electrocardiograma

Chest radiographa

Two-dimensional and Doppler echocardiograma

Magnetic resonance imaging to assess myocardial inflammation and fibrosis

Chemistry:

Serum sodium,a potassium,a calcium,a magnesiuma

Fasting glucose (glycohemoglobin in diabetes mellitus)

Creatinine,a blood urea nitrogena

Albumin,a total protein,a liver function testsa

Lipid profile

Thyroid-stimulating hormonea

Serum iron, transferrin saturation

Urinalysis

Creatine kinase isoforms

Cardiac troponin

Hematology:

Hemoglobin/hematocrita

White blood cell count with differential,a including eosinophils

Erythrocyte sedimentation rate

Initial Evaluation When Specific Diagnoses Are Suspected

DNA sequencing for genetic disease; panel selection based on phenotype

Titers for infection in presence of clinical suspicion:

Acute viral (e.g., coxsackievirus, echovirus, influenza)

Human immunodeficiency virus

Chagas' disease, Lyme disease, toxoplasmosis

Coronary angiography in pts with angina who are candidates for interventiona

Serologies for active rheumatologic disease

Endomyocardial biopsy including sample for electron microscopy when suspecting specific diagnosis with therapeutic implications

Screening for sleep-disordered breathing

a Level I Recommendations from ACC/AHA Practice Guidelines for Chronic Heart Failure in the adult.